Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
Ìý
Also in the Knowledge Center
/ Dec 06, 2017
Effect of throat models and representative deposition profiles on the performance of carrier-based formulations
Read more
Scientific Article
Scientific Article
/ Dec 06, 2017
Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment
Read more
Scientific Article